本页面由Tiger Fintech (Singapore) Pte. Ltd.提供服务

Allogene Therapeutics Inc.

1.40
-0.0500-3.45%
成交量:228.27万
成交额:323.44万
市值:3.06亿
市盈率:-1.15
高:1.45
开:1.43
低:1.38
收:1.45
数据加载中...
2020/02/27

年度报告

10-K - Annual report [Section 13 and 15(d), not S-K Item 405]
2020/02/27

重要事件披露

Current report, items 2.02 and 9.01
2020/02/14

超过5%披露

Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2020/02/13

超过5%披露

[Amend] Statement of acquisition of beneficial ownership by individuals
2019/12/20

重要事件披露

Current report, item 5.02
2019/11/05

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/11/05

重要事件披露

Current report, item 1.01
2019/11/05

重要事件披露

Current report, items 2.02 and 9.01
2019/08/07

季度报告

Quarterly report [Sections 13 or 15(d)]
2019/08/07

重要事件披露

Current report, items 2.02 and 9.01
2019/07/30

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/22

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/22

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/12

持股变动声明

Statement of changes in beneficial ownership of securities
2019/07/01

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/24

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/24

持股变动声明

Statement of changes in beneficial ownership of securities
2019/06/24

持股变动声明

Statement of changes in beneficial ownership of securities